Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Sabra Health Care REIT, Inc. (NASDAQ:SBRAGet Free Report) has earned a consensus rating of “Moderate Buy” from the eight research firms that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $19.25.

Several equities research analysts have recently weighed in on the company. Scotiabank increased their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a report on Friday, October 11th. Wells Fargo & Company raised shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. Mizuho reaffirmed a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Citigroup upgraded shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and increased their target price for the stock from $17.00 to $20.00 in a research note on Friday, September 13th. Finally, JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research report on Tuesday.

Read Our Latest Analysis on SBRA

Sabra Health Care REIT Stock Performance

Shares of SBRA stock opened at $16.80 on Wednesday. The firm has a 50 day moving average of $18.05 and a two-hundred day moving average of $17.44. The stock has a market capitalization of $3.97 billion, a PE ratio of 40.98, a P/E/G ratio of 2.20 and a beta of 1.26. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT has a 52 week low of $12.83 and a 52 week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRAGet Free Report) last announced its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. The company had revenue of $178.00 million during the quarter, compared to analysts’ expectations of $177.19 million. During the same quarter in the previous year, the business posted $0.34 EPS. On average, research analysts predict that Sabra Health Care REIT will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 7.14%. The ex-dividend date was Friday, November 15th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 292.68%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its holdings in shares of Sabra Health Care REIT by 222.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after purchasing an additional 6,819,919 shares during the last quarter. Franklin Resources Inc. boosted its holdings in Sabra Health Care REIT by 12.3% in the third quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock valued at $9,543,000 after acquiring an additional 57,551 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Sabra Health Care REIT during the third quarter valued at about $59,000. Geode Capital Management LLC increased its stake in Sabra Health Care REIT by 1.7% during the third quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock worth $117,165,000 after acquiring an additional 104,533 shares during the last quarter. Finally, Vestcor Inc raised its holdings in shares of Sabra Health Care REIT by 62.5% in the 3rd quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock worth $3,869,000 after purchasing an additional 79,956 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Company Profile

(Get Free Report

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Recommended Stories

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.